TRMU Gene

TRMU Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRMU Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRMU</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>tRNA Mitochondrial Uridine Synthetase (MTU1)</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>MTU1, tRNA Mitochondrial Uridine Synthase, Mtu1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>55687</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>610230</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000100412</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BRR4</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GTPBP3</td>
<td>mt-tRNA modification</td>
</tr>
<tr>
<td class="label">MTO1</td>
<td>Modification enzyme</td>
</tr>
<tr>
<td class="label">MTU1 (TRMU)</td>
<td>2-thiolation</td>
</tr>
<tr>
<td class="label">MSS1</td>
<td>Sulfur donor</td>
</tr>
<tr>
<td class="label">ABCB7</td>
<td>Iron-sulfur cluster</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Cysteine supplementation</td>
<td>Provide sulfur source</td>
</tr>
<tr>
<td class="label">CoQ10</td>
<td>Support ETC</td>
</tr>
<tr>
<td class="label">L-carnitine</td>
<td>Metabolic suppor

TRMU Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRMU Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRMU</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>tRNA Mitochondrial Uridine Synthetase (MTU1)</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>MTU1, tRNA Mitochondrial Uridine Synthase, Mtu1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>55687</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>610230</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000100412</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BRR4</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GTPBP3</td>
<td>mt-tRNA modification</td>
</tr>
<tr>
<td class="label">MTO1</td>
<td>Modification enzyme</td>
</tr>
<tr>
<td class="label">MTU1 (TRMU)</td>
<td>2-thiolation</td>
</tr>
<tr>
<td class="label">MSS1</td>
<td>Sulfur donor</td>
</tr>
<tr>
<td class="label">ABCB7</td>
<td>Iron-sulfur cluster</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Cysteine supplementation</td>
<td>Provide sulfur source</td>
</tr>
<tr>
<td class="label">CoQ10</td>
<td>Support ETC</td>
</tr>
<tr>
<td class="label">L-carnitine</td>
<td>Metabolic support</td>
</tr>
<tr>
<td class="label">NAD+ precursors</td>
<td>Enhance mitochondrial function</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">Human</td>
<td>TRMU</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>TruMU</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>mtu1</td>
</tr>
<tr>
<td class="label">Yeast</td>
<td>MSK1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

TRMU (tRNA Mitochondrial Uridine Synthetase), also known as MTU1 (Mitochondrial tRNA-specific pseudouridine synthase 1), encodes a crucial mitochondrial tRNA-modifying enzyme that catalyzes the 2-thiolation of uridine at wobble positions of mitochondrial tRNAs. This modification is essential for proper mitochondrial translation and function. TRMU deficiency is associated with a spectrum of mitochondrial disorders including acute infantile liver failure, sensorineural hearing loss, and cardiomyopathy.

Gene Information

Normal Function

TRMU encodes a mitochondrial matrix enzyme that catalyzes the 2-thiolation of uridine residues at the wobble position of mitochondrial tRNAs, specifically tRNA^Lys, tRNA^Glu, and tRNA^Gln [1][2]. This modification forms 5-taurinomethyl-2-thiouridine (tm5s2U) moieties, which are critical for:

• Mitochondrial translation fidelity: The thiolated uridine at the wobble position enhances codon-anticodon pairing accuracy, particularly for A-ended codons
• Respiratory chain function: Proper mitochondrial translation is essential for assembling the OXPHOS complexes
• Cellular energy production: Functional OXPHOS complexes I, III, and IV require properly translated mitochondrial-encoded subunits
• Iron-sulfur cluster biogenesis: Mitochondrial translation defects can impair ISC assembly machinery

Structural Features

TRMU contains several functional domains:

• N-terminal mitochondrial targeting sequence
• Central catalytic domain with conserved cysteine residues essential for thiolation activity
• C-terminal domain involved in tRNA recognition and binding

Pathogenic Variants and Disease Associations

Acute Infantile Liver Failure (MIM: 613070)

Homozygous or compound heterozygous pathogenic variants in TRMU cause acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins. The disease presents in infancy with:

• Severe liver dysfunction
• Elevated transaminases
• Hypoglycemia
• Variable neurological involvement

Sensorineural Hearing Loss

TRMU acts as a nuclear modifier influencing the severity of deafness caused by mitochondrial 12S rRNA mutations (e.g., m.1555A>G and m.1494C>T) [7][8]. Individuals with these mitochondrial mutations who also carry TRMU variants often exhibit more severe hearing loss phenotypes. This modification is particularly important because:

• The 12S rRNA mutation predisposes to aminoglycoside-induced hearing loss
• TRMU variants can accelerate the onset and severity of hearing impairment
• Genetic correction of TRMU alleles has shown promise in restoring mitochondrial function in patient-derived cells [9]

Cardiomyopathy and Exercise Intolerance

Some TRMU variant carriers develop cardiomyopathy and exercise intolerance due to impaired mitochondrial respiratory chain function. The heart, with its high energy demands, is particularly vulnerable to mitochondrial translation defects.

MELAS Spectrum

Studies have shown that TRMU expression is downregulated in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) syndrome, contributing to mt-tRNA hypomodification and mitochondrial dysfunction [10]. This suggests potential therapeutic relevance for TRMU-targeted interventions in MELAS.

Molecular Mechanisms

Pathogenic Variant Effects

Pathogenic TRMU variants lead to:

Therapeutic Approaches

Cysteine supplementation has emerged as a potential treatment for some TRMU deficiency cases. The rationale is that cysteine provides sulfur for the thiolation reaction, potentially bypassing partial enzyme deficiency [5][6]. However, response varies based on specific variant and tissue involvement.

Neurodegenerative Disease Relevance

TRMU and mitochondrial tRNA modification have emerged as relevant to neurodegenerative diseases:

Alzheimer's Disease

Recent research has identified altered TRMU expression in AD brains[@xu2023]:

• Reduced TRMU levels in hippocampal and cortical regions
• Contributes to mitochondrial translation deficits observed in AD
• May exacerbate energy failure and synaptic dysfunction

Parkinson's Disease

Mitochondrial tRNA modifications are altered in PD[@zhou2021]:

• TRMU-mediated 2-thiolation is reduced in PD patient tissues
• Contributes to mitochondrial dysfunction in dopaminergic neurons
• May sensitize neurons to environmental toxins

Role in Neurodegeneration

The connection between TRMU and neurodegeneration involves several mechanisms:

• Energy failure: Mitochondrial translation defects reduce OXPHOS capacity
• Oxidative stress: Impaired electron transport chain increases ROS production
• Calcium dysregulation: Mitochondrial dysfunction affects calcium homeostasis
• Aging susceptibility: Age-related decline in tRNA modification exacerbates vulnerability

Animal Models

Zebrafish deletion of Mtu1 (the TRMU ortholog) revealed the essential role of tRNA modification in mitochondrial biogenesis and hearing function [12]. The model demonstrated:

• Severe mitochondrial dysfunction
• Developmental abnormalities
• Auditory deficits
• Phenocopying human disease features

Clinical Relevance

Genetic Testing

TRMU variants should be considered in:

• Infants with unexplained liver failure
• Patients with sensorineural hearing loss, especially with mitochondrial 12S rRNA mutations
• Families with autosomal recessive mitochondrial disorders
• Patients with cardiomyopathy and exercise intolerance
• Individuals with early-onset neurodegeneration

Therapeutic Implications

• Cysteine supplementation trials for TRMU deficiency
• Avoidance of aminoglycosides in individuals with TRMU variants and mitochondrial 12S rRNA mutations
• Monitoring for cardiomyopathy in TRMU variant carriers
• Co-factors targeting mitochondrial function (riboflavin, L-carnitine, CoQ10)

TRMU in Neurodegenerative Disease Research

TRMU represents a potential therapeutic target:

• Small molecule activators: Compounds enhancing TRMU activity
• Gene therapy: Viral delivery of wild-type TRMU
• tRNA modifications: Stabilizing mitochondrial tRNA structure
• Combination approaches: Targeting multiple steps in mitochondrial translation

Research Models and Future Directions

Animal Models

• Zebrafish Mtu1 knockout: Phenocopies human disease
• Mouse models: Conditional knockouts for tissue-specific studies
• Drosophila models: Genetic modifier screening

Future Research Directions

Structural Biology of TRMU

Enzyme Architecture

TRMU (also known as Mtu1) contains several critical structural features:

N-terminal mitochondrial targeting sequence:

• ~30 amino acid presequence
• Amphipathic helix structure
• Cleaved upon mitochondrial import

• Contains conserved cysteine residues (Cys-456, Cys-458, Cys-460)
• Forms the active site for 2-thiolation
• Requires iron-sulfur cluster for activity

• tRNA recognition motifs
• Dimerization interface
• Regulatory elements

Catalytic Mechanism

The 2-thiolation of mitochondrial tRNAs involves:

TRMU in the Mitochondrial tRNA Modification Network

Network Partners

TRMU functions within a larger modification network:

Modification Pathway

The cooperative modification pathway:

Clinical Significance

Prevalence and Epidemiology

TRMU-related disorders are rare:

• Estimated prevalence: 1:100,000 - 1:500,000
• More common in populations with founder mutations
• Both males and females affected
• No ethnic predominance identified

Diagnostic Challenges

Diagnosing TRMU-related disease presents challenges:

• Phenotypic variability
• Overlap with other mitochondrial disorders
• Specialized testing required
• Limited availability of genetic testing

Patient Management

Current management strategies:

• Supportive care for organ dysfunction
• Cysteine supplementation in responsive cases
• Avoidance of aminoglycosides
• Cardiac monitoring
• Hearing evaluation and support

Therapeutic Development Pipeline

Preclinical Approaches

• Enzyme activators: Small molecules enhancing TRMU function
• Gene therapy: AAV-mediated TRMU delivery
• tRNA therapeutics: Modified tRNA administration
• Mitochondrial supplements: CoQ10, L-carnitine, riboflavin

Biomarker Development

Diagnostic and monitoring biomarkers:

• Genetic testing: Sequencing of TRMU coding regions
• Biochemical markers: Mitochondrial translation assays
• Expression analysis: TRMU levels in patient cells
• Functional assays: tRNA modification analysis

TRMU and Aging

Age-Related Changes

TRMU function may decline with age:

• Reduced tRNA modification efficiency
• Accumulation of translational errors
• Progressive mitochondrial dysfunction
• Connection to age-related neurodegeneration

Implications for Age-Related Disease

Age-related TRMU decline may contribute to:

• Increased oxidative stress
• Mitochondrial DNA mutation accumulation
• Cellular energy deficits
• Susceptibility to neurodegenerative disease

Cross-References

• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• [MELAS Syndrome](/diseases/melas-syndrome)
• [Mitochondrial Deafness](/diseases/mitochondrial-deafness)
• [GTPBP3 Gene](/genes/gtpbp3)
• [MTO1 Gene](/genes/mto1)
• [Oxidative Phosphorylation](/mechanisms/oxidative-phosphorylation)
• [Mitochondrial Translation](/mechanisms/mitochondrial-translation)
• [Iron-Sulfur Cluster Biogenesis](/mechanisms/iron-sulfur-cluster-biogenesis)

Animal Models and Research Insights

Zebrafish Models

The zebrafish (Danio rerio) has proven an invaluable model for studying TRMU function:

Mtu1 Knockout Phenotype:

• Developmental arrest at early stages
• Mitochondrial dysfunction in multiple tissues
• Cardiac abnormalities
• Neurological defects
• Phenocopying human mitochondrial disease

• Partial knockdown reveals dose-dependent effects
• Tissue-specific vulnerability
• Rescue experiments with human TRMU mRNA

Mouse Models

Murine models have provided additional insights:

• Conditional knockouts: Tissue-specific deletion
• Knock-in models: Patient-specific mutations
• Transgenic overexpression: Rescue studies

Cellular Models

Fibroblast Studies:

• Patient-derived fibroblasts show reduced thiolation
• Respiratory chain deficiency
• Sensitivity to oxidative stress

• Neuronal differentiation defects
• Mitochondrial dysfunction
• Disease modeling potential

Therapeutic Development

Small Molecule Approaches

Gene Therapy Strategies

• AAV vectors: CNS delivery
• CRISPR correction: Variant-specific
• mRNA delivery: Transient expression

Antioxidant Approaches

• MitoQ: Mitochondrial-targeted antioxidant
• Idebenone: ETC support
• Vitamin C: Antioxidant support

Clinical Management

Diagnostic Approaches

Treatment Strategies

Acute Management:

• Supportive care for liver failure
• Management of seizures
• Cardiac monitoring

• Cysteine supplementation trials
• Avoidance of aminoglycosides
• Regular cardiac evaluation
• Physical therapy

Prognosis

• Infantile onset: Variable, can be severe
• Later onset: Generally better prognosis
• Modifier genes: Influence disease severity

TRMU in Comparative Biology

Evolutionary Conservation

TRMU orthologs are found across eukaryotes:

Functional Conservation

The thiolation function is evolutionarily conserved from bacteria to mammals, indicating its fundamental importance in mitochondrial translation.

Research Methods

Key Techniques

• tRNA sequencing: Modified nucleoside analysis
• Northern blotting: tRNA modification status
• Mitochondrial translation assays: Protein synthesis measurement
• Respirometry: OCR measurements
• Proteomics: OXPHOS complex analysis

Model Systems

• Yeast genetics: Functional complementation
• Cell-free systems: In vitro translation
• Cryo-EM: Structure determination

Public Health Significance

Disease Burden

Mitochondrial diseases collectively affect approximately 1 in 5,000 individuals, with TRMU-related disease representing a small but significant subset.

Economic Impact

• Healthcare costs for mitochondrial disease
• Loss of productivity
• Caregiver burden

Awareness Needs

• Improved diagnostic capacity
• Newborn screening considerations
• Family planning support

Future Directions

Research Priorities

Unmet Needs

• Effective treatments for severe disease
• Biomarkers for treatment response
• Understanding of tissue specificity
• Prevention strategies

External Resources

• [NCBI Gene: TRMU](https://www.ncbi.nlm.nih.gov/gene/55687)
• [UniProt: TRMU](https://www.uniprot.org/uniprot/Q9BRR4)
• [OMIM: TRMU](https://www.omim.org/entry/610230)
• [GeneCards: TRMU](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRMU)

References